about
Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?Pathophysiology of Non Alcoholic Fatty Liver DiseaseGlucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver diseaseThe interaction of metabolic factors with HCV infection: does it matter?Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data.Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease.Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver diseaseLiver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment.Nonalcoholic fatty liver disease and the metabolic syndrome.Is liver disease a threat to patients with metabolic disorders?Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.Insulin resistance: a metabolic pathway to chronic liver disease.Estimates of hepatic glyceroneogenesis in type 2 diabetes mellitus in humans.NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat LoadNon-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart diseaseMBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014.Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver diseaseFrom the metabolic syndrome to NAFLD or vice versa?Obesity and liver cancer.Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance.Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander.A "systems medicine" approach to the study of non-alcoholic fatty liver disease.Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.Obesity: Childhood obesity: time bomb for future burden of chronic liver disease.Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study.Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes.SIGNIFICANT IMPROVEMENT OF GLYCAEMIC CONTROL IN DIABETIC PATIENTS WITH HCV INFECTION RESPONDING TO DIRECT-ACTING ANTIVIRAL AGENTS.IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.Undernutrition, risk of malnutrition and obesity in gastroenterological patients: A multicenter study.A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas.HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
P50
Q26776338-3F3091B2-7E8D-4E50-AF71-0916C5E387EDQ28070011-660C1742-7EC0-451C-82D2-0AD0E067F7DDQ28539434-74D9B7A7-63BF-4D80-A096-F97C463E023DQ30412494-F41BE9BB-BC76-419A-9F57-E41CF3F67A64Q30877287-DC496100-502B-4CBF-9D67-F99F0E261BBDQ33756919-1D857DE5-AC00-4C45-A06F-E4511519E14AQ34219651-6C060E9F-4BB6-4FC9-BE57-F76B2A420DEEQ35809618-8130ECDA-AB91-4B46-A39D-9A36C5831945Q35810018-27450682-AFD5-4676-B3D3-0BFB60B8F44AQ35961708-D7A969C0-7D9B-4D84-9DE9-2C4F7D76A0EDQ36180393-8110813D-CD28-42EC-896B-225C30999A67Q36265230-E3005714-FF61-4DE0-9B4D-04D69F327B74Q36294146-D2B4E631-6FFC-4A2D-B232-A9AD93CC4C66Q36297331-B7DAAD60-D1F1-4572-AE25-EE54C4115FD7Q36501828-7FF466BA-35BE-46FC-858A-BAF5E7FB6A65Q36839912-542D5506-2442-43FC-AA6E-EEF409C19765Q36846967-9EDDA52E-CF42-4A4D-A861-9EF0CFA88F12Q37002532-4AE6E3E2-A047-455A-AC2E-F113194701DFQ37264708-3AC3EC48-7D51-4777-9B13-6EA8E826E464Q37284503-623BFCFB-F422-4219-92B0-9F3824C3EB13Q37596730-119D5FA7-8022-42B9-8979-482B588956CEQ37703968-52E1E805-8207-46AA-A653-D4DC133DC04BQ38166064-C23A4AC0-528A-4FC8-B1EB-7AD0BAB6DC6FQ38287516-14084CED-AAA6-485C-903A-B960C8951841Q38588331-8EE7B755-1567-45D1-8020-855C13EF33DCQ38677429-0523153E-1B36-4BDC-B2C6-9FC9CCEAEDEFQ38803869-ED5B8991-D0A5-47CC-BBA8-9B077C3B9541Q38835054-7785542C-4841-4983-8E50-C8B5680DD160Q38859044-0FF11E81-1119-40D9-8759-25F99123F717Q40153908-9F9A9686-2F22-400C-B7F7-DDF58157E8C7Q40813737-7FA3D828-48DA-46E5-9710-30D63AF717BDQ41928201-831AAADB-0EFF-4591-99B9-C0B434ECDD41Q42222091-3B1E7363-CF55-4AB2-B48C-2BF761A3275AQ42424404-AE5E4FC0-BDF4-42CD-9A65-6E3C1C3E95B0Q42654018-BC876446-DAAB-460F-B937-E763BCF8D5EAQ42980807-EED2FD35-0524-4691-A617-6DC8A26B0359Q42987060-5CEF39E5-F62C-4FFC-A34A-14EBD6AA6231Q43034053-E03360C0-EBAC-4E02-B42D-EB71E11F3C3AQ43036848-95DA148A-8025-4DCE-AA0B-8573AB9D2D2BQ43237367-9ABABB28-7C80-47B3-8810-B2381E261041
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
Elisabetta Bugianesi
@ast
Elisabetta Bugianesi
@en
Elisabetta Bugianesi
@es
Elisabetta Bugianesi
@nl
type
label
Elisabetta Bugianesi
@ast
Elisabetta Bugianesi
@en
Elisabetta Bugianesi
@es
Elisabetta Bugianesi
@nl
prefLabel
Elisabetta Bugianesi
@ast
Elisabetta Bugianesi
@en
Elisabetta Bugianesi
@es
Elisabetta Bugianesi
@nl
P31
P496
0000-0002-0502-4381